Medindia

X

Johnson & Johnson Nearing Deal to Buy Cancer Drug Maker Pharmacyclics

by Vishnuprasad on  March 6, 2015 at 7:58 PM Cancer News   - G J E 4
The Financial Times on Wednesday reported that Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days.
 Johnson & Johnson Nearing Deal to Buy Cancer Drug Maker Pharmacyclics
Johnson & Johnson Nearing Deal to Buy Cancer Drug Maker Pharmacyclics
Advertisement

A bid from J&J is expected to value Pharmacyclics near its $17.5 billion market value or at a premium, FT said. Shares of Pharmacyclics, which markets blood cancer drug Imbruvica with J&J's Janssen unit, increased about 3 percent in extended trading.

Advertisement
Pharmacyclics has earlier said that sales of Imbruvica, which has U.S. approvals for four forms of blood cancer, are expected to touch $1 billion in the United States this year.

Bloomberg reported last month that Pharmacyclics was mulling a sale and had attracted the interest of J&J and Novartis AG. Any interest from J&J would be logical, considering its already established relationship with Pharmacyclics, experts in the industry said.



Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All